Table 1.

Clinical information of patients analyzed in the study.

		CD	Non-IBD
Number of patients		25	15
Age	Mean	47	66
	Interval	(30–70)	(37–80)
Gender	Male	9	6
	Female	16	9
CD phenotype	B2 or stricturing	15	-
	B3 or penetrant	10	-
Concomitant Medication	Azathioprine	16	-
	Methotrexate	5	-
	6-Mercaptopurine	3	-
	Biological Therapy (anti-TNFα)	24	-